Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With Schizophrenia
Clinical trial NCT07523256 · COMPLETED
Trial details
- NCT number
- NCT07523256
- Sponsor
- Rinvil Renaldi
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2026-01-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.